|
Chemistry and Biochemistry |
|
|
|
Chapter 1 The Chemistry of Selenium |
|
|
3 | (13) |
|
|
|
|
1.1 Chemical Properties of Selenium |
|
|
3 | (3) |
|
1.2 Organoselenium Compounds |
|
|
6 | (3) |
|
1.3 Selenium in Soil and Foods |
|
|
9 | (7) |
|
|
11 | (1) |
|
Keys Facts of Selenoproteins |
|
|
11 | (1) |
|
Definitions and Explanations of Key Terms |
|
|
12 | (1) |
|
|
13 | (1) |
|
|
13 | (3) |
|
Chapter 2 Biochemistry and Molecular Biology of Selenoproteins |
|
|
16 | (24) |
|
|
|
|
|
2.1 Selenoproteins in Mammals |
|
|
16 | (7) |
|
2.1.1 Thioredoxin Reductases |
|
|
16 | (1) |
|
2.1.2 Glutathione Peroxidases |
|
|
17 | (1) |
|
|
17 | (5) |
|
|
22 | (1) |
|
2.1.5 Iodothyronine Deiodinases |
|
|
22 | (1) |
|
2.1.6 Selenoprotein R is a Methionine-Sulfoxide-Reductase |
|
|
22 | (1) |
|
2.1.7 Selenoproteins Involved in Protein Biosynthesis, Folding or Degradation |
|
|
23 | (1) |
|
2.2 Selenoprotein Biosynthesis |
|
|
23 | (17) |
|
2.2.1 Biosynthesis of Selenocysteine |
|
|
23 | (3) |
|
2.2.2 Translation of Selenoproteins |
|
|
26 | (6) |
|
|
32 | (1) |
|
Key Facts: Recoding of UGA |
|
|
32 | (1) |
|
Key Facts: Mutations in SECISBP2 |
|
|
32 | (1) |
|
|
33 | (1) |
|
|
33 | (1) |
|
|
34 | (6) |
|
Chapter 3 Synthesis of Organoselenium Derivatives of Biological Relevance |
|
|
40 | (25) |
|
|
|
Jose G. Fernandez-Bolanos |
|
|
|
40 | (1) |
|
3.2 Isoselenocyanates and Related Selenoxo Compounds |
|
|
41 | (4) |
|
|
45 | (7) |
|
3.4 Ebselen and Derivatives |
|
|
52 | (3) |
|
|
55 | (10) |
|
|
58 | (1) |
|
|
58 | (1) |
|
Definitions of Words and Terms |
|
|
58 | (1) |
|
|
59 | (1) |
|
|
60 | (1) |
|
|
60 | (5) |
|
Chapter 4 Chemistry and Activity of Selenium Dioxide and Selenite Ions |
|
|
65 | (16) |
|
|
|
65 | (1) |
|
4.2 Oxidation State and Speciation in Aqueous Solution |
|
|
66 | (2) |
|
4.3 SeO32- as a Nutritional Supplement |
|
|
68 | (1) |
|
|
68 | (3) |
|
4.4.1 Oxidative Activity of SeO2 |
|
|
68 | (1) |
|
4.4.2 ROS Formation and SeO32- |
|
|
69 | (1) |
|
4.4.3 Chemopreventive and Chemotherapeutic Activity of SeO32- |
|
|
70 | (1) |
|
4.5 Interactions with Metal Ions |
|
|
71 | (2) |
|
4.5.1 Role of SeO32- in Mediating Metal Toxicity |
|
|
71 | (1) |
|
4.5.2 Se02 and SeO32- as Antioxidants |
|
|
72 | (1) |
|
|
73 | (8) |
|
|
74 | (1) |
|
|
74 | (2) |
|
Definitions and Explanation of Key Terms |
|
|
76 | (1) |
|
|
77 | (1) |
|
|
77 | (4) |
|
Chapter 5 Chemistry and Biochemistry: Selenium Species in Fish |
|
|
81 | (22) |
|
|
|
|
|
|
|
81 | (1) |
|
|
82 | (3) |
|
5.3 Low Molecular Mass Organoselenium Compounds |
|
|
85 | (7) |
|
|
92 | (11) |
|
|
92 | (1) |
|
|
92 | (1) |
|
Key Facts of Selenoprotein L (SelL) |
|
|
92 | (1) |
|
Key Facts of Fish 15 kDa Selenoprotein-like Protein (Fep15) |
|
|
93 | (1) |
|
Definitions of Words and Terms |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
94 | (9) |
|
|
|
Chapter 6 Current Analytical Strategies and Techniques Related to Selenoproteins in Foods |
|
|
103 | (23) |
|
Miguel Angel Garcia-Sevillano |
|
|
Macarena Gonzalez-Fernandez |
|
|
|
|
|
103 | (1) |
|
6.1.1 Selenoproteins in Food |
|
|
104 | (1) |
|
6.2 The Role of ICP-MS in Selenoproteins Speciation |
|
|
104 | (2) |
|
6.3 Sample Preparation Procedures for Selenoproteins Speciation |
|
|
106 | (3) |
|
6.3.1 Conventional Sample Preparation Procedures for Selenoproteins Speciation |
|
|
106 | (1) |
|
6.3.2 New Trends in Extraction Procedures for Selenoproteins from Food Matrices |
|
|
107 | (1) |
|
|
108 | (1) |
|
6.3.4 Stability of Selenoproteins During Storage |
|
|
109 | (1) |
|
6.4 Current Analytical Strategies and Hyphenated Techniques for Selenoproteins Speciation in Foods |
|
|
109 | (6) |
|
6.4.1 Separation and Detections Techniques for Selenoproteins Based on Liquid Chromatography |
|
|
110 | (3) |
|
6.4.2 Electrophoretic Techniques |
|
|
113 | (1) |
|
6.4.3 Isotopic Dilution Analysis in Selenoproteins Quantification |
|
|
114 | (1) |
|
6.4.4 Speciation Methods to Evaluate Selenium Status in Human |
|
|
115 | (1) |
|
6.5 Selected Cases Studies |
|
|
115 | (11) |
|
6.5.1 Selenoproteins in Meat |
|
|
115 | (1) |
|
6.5.2 Selenoproteins in Seafood |
|
|
116 | (1) |
|
6.5.3 Selenoproteins in Milk |
|
|
117 | (1) |
|
6.5.4 Selenoproteins in Vegetables |
|
|
118 | (1) |
|
6.5.5 Selenoproteins in Food Supplements |
|
|
118 | (3) |
|
|
121 | (1) |
|
Key Facts of Selenium in Foods |
|
|
121 | (1) |
|
Key Facts of Selenium Analysis in Foods |
|
|
121 | (1) |
|
Definitions of Words and Terms |
|
|
122 | (1) |
|
|
122 | (2) |
|
|
124 | (2) |
|
Chapter 7 Focus on Determination of Selenocysteine and Selenomethionine in Foodstuffs of Animal Origin by 2D Size-Exclusion Reversed-Phase HPLC-ICP-MS |
|
|
126 | (18) |
|
|
|
|
|
|
126 | (2) |
|
7.2 Selenium in Foodstuffs of Animal Origin |
|
|
128 | (3) |
|
7.2.1 Meat and Meat Products |
|
|
128 | (1) |
|
|
129 | (1) |
|
|
130 | (1) |
|
|
130 | (1) |
|
7.3 Determination of Selenomethionine and Selenocysteine by 2D HPLC-ICP-MS |
|
|
131 | (7) |
|
7.3.1 Analytical Procedure |
|
|
131 | (4) |
|
7.3.2 Selenoamino Acid Distribution in Foodstuffs of Animal Origin |
|
|
135 | (3) |
|
|
138 | (6) |
|
|
138 | (1) |
|
Key Facts of Selenoaminoacids Determination |
|
|
138 | (1) |
|
|
139 | (1) |
|
|
140 | (1) |
|
|
140 | (4) |
|
Chapter 8 Some Aspects of Selenium Determination Employing Solid-Phase Extraction and Atomic Absorption Spectrometry |
|
|
144 | (14) |
|
Ana Lucia Silva Figueiredo de Paiva |
|
|
|
|
|
Cristiana Schmidt de Magalhaes |
|
|
|
|
145 | (13) |
|
8.1.1 Se species and Concentrations in Different Samples |
|
|
145 | (3) |
|
8.1.2 Techniques Used in Selenium Determination |
|
|
148 | (1) |
|
8.1.3 Solid-Phase Extraction (SPE) to Determine Se |
|
|
149 | (3) |
|
|
152 | (1) |
|
Key Facts: Analytical Aspects in Selenium Determination |
|
|
152 | (1) |
|
Definitions of Words and Terms |
|
|
153 | (1) |
|
|
154 | (1) |
|
|
155 | (3) |
|
Chapter 9 Identification of Selenometabolites in Animals and Plants by Mass Spectrometry |
|
|
158 | (15) |
|
|
9.1 Analytical Techniques for the Detection and Identification of Selenometabolites |
|
|
158 | (4) |
|
9.1.1 Inductively Coupled Argon Plasma Mass Spectrometry and Speciation |
|
|
158 | (2) |
|
9.1.2 Electrospray Ionization Mass Spectrometry |
|
|
160 | (1) |
|
|
161 | (1) |
|
9.2 Identification of Selenometabolites |
|
|
162 | (6) |
|
|
162 | (1) |
|
9.2.2 Unique Selenoamino Acids |
|
|
163 | (5) |
|
|
168 | (5) |
|
|
168 | (1) |
|
Key Facts of Selenometabolites |
|
|
168 | (1) |
|
Definitions and Explanations of Key Terms |
|
|
169 | (1) |
|
|
169 | (1) |
|
|
170 | (3) |
|
Chapter 10 Bioavailability of Selenium and Selenium Compounds in Foodstuff by In Vivo Testing |
|
|
173 | (24) |
|
|
|
|
173 | (6) |
|
10.1.1 Bioaccessibility/Bioavailability/Bioactivity Definitions |
|
|
174 | (2) |
|
10.1.2 Bioavailability Assessment: In Vivo Tests |
|
|
176 | (3) |
|
10.2 In Vivo Testing for Assessing Selenium Species Bioaccessibility/Bioavailability |
|
|
179 | (18) |
|
10.2.1 In Vivo Tests in Humans |
|
|
179 | (3) |
|
10.2.2 In Vivo Tests in Animals |
|
|
182 | (5) |
|
|
187 | (1) |
|
Key Facts of In Vivo Testing for Bioavailability Assessment |
|
|
188 | (1) |
|
Definitions of Words and Terms |
|
|
188 | (1) |
|
Abbreviations and Acronyms |
|
|
189 | (1) |
|
|
189 | (8) |
|
Chapter 11 Bioavailability of Selenium and Selenium Compounds in Foodstuff by In Vitro Testing |
|
|
197 | (24) |
|
|
|
|
197 | (1) |
|
11.2 Bioavailability Assessment: In Vitro Tests |
|
|
198 | (6) |
|
11.2.1 In Vitro Static Models |
|
|
199 | (4) |
|
11.2.2 In Vitro Dynamic Models |
|
|
203 | (1) |
|
11.3 In Vitro Gastrointestinal Extraction Methods to Selenium Species Bioaccessibility/Bioavailability in Foodstuff |
|
|
204 | (17) |
|
11.3.1 Oral Bioaccessibility/Bioavailability of Selenium in Food Samples |
|
|
204 | (8) |
|
11.3.2 Effect of Food Processing on Selenium Species Bioaccessibility/Bioavailability |
|
|
212 | (1) |
|
11.3.3 Effect of Sample Composition on Selenium Species Bioaccessibility/Bioavailability |
|
|
213 | (1) |
|
|
214 | (1) |
|
Key Facts of In Vitro Testing for Bioavailability Assessment |
|
|
215 | (1) |
|
Definitions of Words and Terms |
|
|
215 | (1) |
|
Abbreviations and Acronyms |
|
|
216 | (1) |
|
|
216 | (5) |
|
Chapter 12 Assay of Selenium in Dietary Supplements |
|
|
221 | (19) |
|
|
|
|
|
221 | (2) |
|
12.2 Basic Characteristics of Selenium-Containing Dietary Supplements |
|
|
223 | (1) |
|
12.3 Sample Pretreatment and Separation of Selenium |
|
|
224 | (2) |
|
12.4 Instrumental Techniques for Selenium Assay in Dietary Supplements |
|
|
226 | (3) |
|
12.4.1 Electrochemical Methods |
|
|
226 | (1) |
|
12.4.2 Spectroscopic Methods |
|
|
227 | (2) |
|
12.5 Selenium Speciation in Dietary Supplements |
|
|
229 | (3) |
|
|
232 | (8) |
|
|
233 | (1) |
|
|
234 | (1) |
|
Key Facts of Inductively Coupled Plasma/Optical Emission Spectrometry (ICP-OES) |
|
|
234 | (1) |
|
Key Facts of Inductively Coupled Plasma/Mass Spectrometry (ICP-MS) |
|
|
234 | (1) |
|
Key Facts of Electrothermal Atomic Absorption Spectrometry (ETAAS) |
|
|
234 | (1) |
|
Definitions of Words and Terms |
|
|
234 | (2) |
|
|
236 | (1) |
|
|
236 | (4) |
|
Chapter 13 Selenium as a Modulator of Fourier Transform Infrared Spectra in Cancer |
|
|
240 | (18) |
|
|
|
|
240 | (5) |
|
13.1.1 Sources of Selenium |
|
|
241 | (1) |
|
13.1.2 Selenoproteins and their Biosynthesis |
|
|
242 | (1) |
|
13.1.3 Selenium -- Its Role in Cancer |
|
|
243 | (2) |
|
13.2 Fourier Transform Infrared (FTIR) Spectroscopy |
|
|
245 | (3) |
|
13.2.1 FTIR -- Applications in Medical Sciences |
|
|
246 | (1) |
|
|
247 | (1) |
|
13.3 Selenium and FTIR Spectra |
|
|
248 | (4) |
|
|
252 | (6) |
|
|
253 | (1) |
|
|
253 | (1) |
|
Definition of Words and Key Terms |
|
|
253 | (1) |
|
|
254 | (1) |
|
|
254 | (4) |
|
Chapter 14 Selenium Status Assessment by Questionnaire in Clinical and Cardiovascular Studies |
|
|
258 | (15) |
|
|
|
14.1 Introduction: Need for Selenium Status Assessment Tools in Clinical Studies |
|
|
258 | (1) |
|
14.2 Clinical Assessment Tools for Long-Term Exposures |
|
|
259 | (1) |
|
14.2.1 Food-Frequency Questionnaires (FFQ) |
|
|
259 | (1) |
|
14.2.2 Other Questionnaire-Based Assessment Options |
|
|
260 | (1) |
|
14.3 Comparison of FFQ with Clinical Biomarkers for Assessment of Selenium Status |
|
|
260 | (3) |
|
14.3.1 Duration of Exposure Assessed -- Long-Term versus Short Term |
|
|
260 | (1) |
|
14.3.2 Categorized versus Continuous Estimates |
|
|
261 | (1) |
|
14.3.3 Geographical Variations |
|
|
261 | (1) |
|
|
262 | (1) |
|
14.3.5 Assessment and Adjustment for Other Dietary Factors |
|
|
262 | (1) |
|
|
262 | (1) |
|
|
263 | (1) |
|
|
263 | (1) |
|
14.3.9 Selenium as an Acute Phase Reactant |
|
|
263 | (1) |
|
14.4 Summary and Future Research Prospects |
|
|
263 | (10) |
|
|
265 | (1) |
|
Definition of Key Words and Terms |
|
|
265 | (1) |
|
Key Facts of Food-Frequency Questionnaire (FFQ) |
|
|
266 | (1) |
|
|
267 | (1) |
|
|
267 | (6) |
|
|
|
Chapter 15 Functional Foods Enriched in Selenium |
|
|
273 | (18) |
|
|
|
|
|
|
|
15.1 Functional Foods, Nutraceuticals and Ready-to-Use Therapeutic Foods: Selenium-Enriched Foods |
|
|
273 | (2) |
|
15.2 Selenium Biotransformation in Microalgae and Yeast |
|
|
275 | (4) |
|
15.2.1 Selenized Yeast as Selenium Source |
|
|
275 | (1) |
|
15.2.2 Microalgae as Selenium-Containing Functional Food |
|
|
276 | (3) |
|
15.3 Nutritional Significance and Toxicological Aspects of Selenium Species |
|
|
279 | (2) |
|
15.4 Selenium Bioaccessibility and Bioavailability in Food |
|
|
281 | (3) |
|
15.4.1 Selenium Bioavailability in Fish |
|
|
282 | (1) |
|
15.4.2 Selenium Bioavailability in Meat |
|
|
283 | (1) |
|
15.4.3 Selenium Bioavailability in Milk and Derived Products |
|
|
283 | (1) |
|
15.4.4 Selenium Bioavailability in Se-Fortified Foodstuffs |
|
|
283 | (1) |
|
15.5 Antagonistic and Synergistic Interactions of Selenium with Other Elements |
|
|
284 | (7) |
|
15.5.1 Selenium Against Mercury Toxicity |
|
|
285 | (1) |
|
15.5.2 The Interaction of Selenium and Iodine in Human Health: Food Supplemented with Iodine and Selenium |
|
|
285 | (2) |
|
|
287 | (1) |
|
Key Facts of Saccharomyces cerevisiae |
|
|
287 | (1) |
|
Definitions of Words and Terms |
|
|
288 | (1) |
|
|
288 | (1) |
|
|
289 | (2) |
|
Chapter 16 Selenium in Parenteral Nutrition |
|
|
291 | (13) |
|
|
|
16.1 A Historical Overview |
|
|
291 | (2) |
|
16.2 Physiology and Biological Function |
|
|
293 | (1) |
|
|
293 | (2) |
|
16.4 A Focus on Critical Care |
|
|
295 | (2) |
|
|
296 | (1) |
|
|
296 | (1) |
|
16.4.3 Gastrointestinal Surgery |
|
|
297 | (1) |
|
|
297 | (1) |
|
16.6 Monitoring Selenium Status |
|
|
298 | (1) |
|
|
299 | (5) |
|
|
299 | (1) |
|
|
300 | (1) |
|
Key Facts of the Development of Parenteral Nutrition |
|
|
300 | (1) |
|
Key Facts of Parenteral Nutrition |
|
|
301 | (1) |
|
|
302 | (1) |
|
|
303 | (1) |
|
|
303 | (1) |
|
Chapter 17 Biofortification of Fruit and Vegetables with Selenium |
|
|
304 | (20) |
|
|
|
|
|
|
304 | (2) |
|
|
306 | (3) |
|
|
309 | (1) |
|
|
310 | (1) |
|
|
311 | (1) |
|
|
312 | (2) |
|
|
314 | (1) |
|
|
314 | (1) |
|
17.9 Conclusions and Future Prospects |
|
|
315 | (9) |
|
|
316 | (1) |
|
Key Facts of Human Se Nutrition |
|
|
317 | (1) |
|
Key Facts of Se Metabolism in Plants |
|
|
317 | (1) |
|
Definitions of Words and Terms |
|
|
318 | (1) |
|
|
318 | (1) |
|
|
319 | (1) |
|
|
319 | (5) |
|
Chapter 18 Biofortification of Legumes with Selenium in Semiarid Conditions |
|
|
324 | (17) |
|
|
|
|
|
324 | (3) |
|
18.2 Importance of Legumes in Cropping Systems |
|
|
327 | (1) |
|
18.3 Legumes in the Mediterranean Diet |
|
|
327 | (1) |
|
18.4 Selenium Biofortification in the Main Legume Crops under Mediterranean Conditions |
|
|
328 | (6) |
|
|
329 | (1) |
|
|
329 | (2) |
|
|
331 | (2) |
|
|
333 | (1) |
|
18.5 Other Considerations for Se Agronomic Biofortification under Semiarid Conditions |
|
|
334 | (7) |
|
|
335 | (1) |
|
|
336 | (5) |
|
Chapter 19 Selenium in Saliva and Impact on Health |
|
|
341 | (13) |
|
|
|
|
19.1 Saliva and Salivary Components |
|
|
341 | (1) |
|
|
342 | (2) |
|
|
344 | (1) |
|
19.4 Selenium and Dental Caries |
|
|
345 | (1) |
|
19.5 Cariogenic Effect of Selenium in Laboratory Animals |
|
|
346 | (1) |
|
19.6 The Role of Selenium in the Antioxidant Activity of Saliva |
|
|
347 | (2) |
|
|
349 | (5) |
|
|
349 | (1) |
|
Key Facts of Salivary Selenium |
|
|
349 | (1) |
|
Key Facts of Selenium and Teeth |
|
|
350 | (1) |
|
Definitions of Words and Terms |
|
|
350 | (1) |
|
|
351 | (2) |
|
|
353 | (1) |
|
Chapter 20 Selenohomolanthionine and Its Potential Use in Medicine and Nutrition |
|
|
354 | (9) |
|
|
20.1 Identification of Selenohomolanthionine and Its Derivatives in Biota |
|
|
354 | (3) |
|
20.2 Biosynthetic Pathway of Selenohomolanthionine in Plants gag |
|
|
|
20.3 Metabolic Pathway of Selenohomolanthionine in Animals |
|
|
357 | (1) |
|
20.4 Antiseptic Effect of Selenohomolanthionine |
|
|
358 | (5) |
|
|
359 | (1) |
|
Key Facts of Selenohomolanthionine |
|
|
360 | (1) |
|
Definitions and Explanations of Key Terms |
|
|
360 | (1) |
|
|
360 | (1) |
|
|
360 | (3) |
|
Chapter 21 Therapy with Selenium Cocktails and Co-use of Lycopene and Selenium |
|
|
363 | (14) |
|
|
|
|
|
|
363 | (4) |
|
|
363 | (1) |
|
21.1.2 Selenium Deficiency |
|
|
364 | (1) |
|
21.1.3 Selenium and Cancer |
|
|
364 | (1) |
|
21.1.4 Selenium and Other Human Diseases |
|
|
365 | (1) |
|
|
365 | (2) |
|
|
367 | (1) |
|
|
367 | (1) |
|
21.2.2 Lycopene and Cancer |
|
|
367 | (1) |
|
21.2.3 Lycopene and Other Human Diseases |
|
|
368 | (1) |
|
21.3 Co-use of Selenium, Lycopene and Serenoa repens |
|
|
368 | (3) |
|
|
371 | (6) |
|
|
371 | (1) |
|
Key Facts of Selenium, Lycopene and Serenoa repens |
|
|
372 | (1) |
|
|
372 | (1) |
|
|
373 | (4) |
|
Chapter 22 Selenium and Cancer |
|
|
377 | (14) |
|
Katarzyna Jaworska-Bieniek |
|
|
|
|
|
|
|
|
|
|
Anna Wiechowska-Kozlowska |
|
|
|
|
|
|
|
|
|
|
|
|
|
Aleksandra Toloczko-Grabarek |
|
|
|
|
|
|
|
378 | (1) |
|
22.2 Forms of Selenium and Its Metabolism in Organisms |
|
|
378 | (2) |
|
22.3 Medical Applications |
|
|
380 | (4) |
|
22.3.1 Selenium and Cancer Mortality |
|
|
380 | (1) |
|
22.3.2 Selenium as a Marker of Selection for Control Examinations in Surveillance |
|
|
381 | (2) |
|
22.3.3 Selenium and Cancer Prevention |
|
|
383 | (1) |
|
|
384 | (7) |
|
|
385 | (1) |
|
|
385 | (1) |
|
Definitions of Words and Terms |
|
|
385 | (2) |
|
|
387 | (1) |
|
|
387 | (4) |
|
Chapter 23 Selenium and Skin Cancer |
|
|
391 | (17) |
|
|
|
|
23.1 Etiology and Genetics of Skin Cancers |
|
|
391 | (2) |
|
23.2 Dietary Selenium and Selenium Metabolism |
|
|
393 | (1) |
|
23.3 Se and the Risk for Skin Cancer |
|
|
394 | (4) |
|
23.4 Selenoproteins and the Skin |
|
|
398 | (2) |
|
23.4.1 Glutathione Peroxidases |
|
|
398 | (1) |
|
23.4.2 Methionine Sulfoxide Reductase |
|
|
399 | (1) |
|
23.4.3 Thioredoxin Reductases |
|
|
399 | (1) |
|
23.5 Studies of Se and Skin Cancer in Model Systems |
|
|
400 | (8) |
|
|
403 | (1) |
|
|
403 | (1) |
|
Definitions and Explanations of Key Terms |
|
|
403 | (1) |
|
|
404 | (1) |
|
|
405 | (3) |
|
Chapter 24 Selenium and Cancer Metastasis |
|
|
408 | (20) |
|
|
|
|
408 | (2) |
|
|
408 | (1) |
|
24.1.2 Preclinical and Clinical Evidence for the Beneficial Effect of Se in Regard to Cancer |
|
|
409 | (1) |
|
24.2 Se in Cancer Metastasis |
|
|
410 | (12) |
|
24.2.1 Se and Cancer Metastasis |
|
|
410 | (2) |
|
|
412 | (1) |
|
24.2.3 The Effect of Se on Cell Integrity and Epithelial-Mesenchymal Transition (EMT) |
|
|
412 | (3) |
|
24.2.4 The Effect of Se on Cell Migration, Invasion and Extracellular Matrix (ECM) Degradation |
|
|
415 | (3) |
|
|
418 | (1) |
|
24.2.6 The Effects of Se on ECM Degradation and Angiogenesis |
|
|
419 | (3) |
|
24.3 The Future and Challenges of the Application of Se on Cancer and Metastasis Prevention |
|
|
422 | (6) |
|
|
423 | (1) |
|
|
423 | (1) |
|
|
424 | (1) |
|
|
424 | (71) |
|
|
495 | |
|
Chapter 25 The Selenium and Vitamin E Cancer Prevention Trial (SELECT): Prevention of Prostate Cancer Using Selenium and/or Vitamin E in the SELECT Cancer Prevention Trial |
|
|
428 | (30) |
|
|
|
|
428 | (2) |
|
|
430 | (3) |
|
25.2.1 Definition and Sources |
|
|
430 | (1) |
|
25.2.2 Metabolism and Biological Activities |
|
|
430 | (2) |
|
25.2.3 Nutritional Requirements |
|
|
432 | (1) |
|
|
433 | (2) |
|
25.3.1 Definition and Sources |
|
|
433 | (1) |
|
25.3.2 Metabolism and Biological Activities |
|
|
434 | (1) |
|
25.3.3 Nutritional Requirements |
|
|
434 | (1) |
|
25.4 Rationale for SELECT |
|
|
435 | (7) |
|
25.4.1 Prostate-Cancer Prevention by Selenium |
|
|
435 | (3) |
|
25.4.2 Prostate-Cancer Prevention by Vitamin E |
|
|
438 | (2) |
|
25.4.3 Prostate-Cancer Prevention by Selenium and Vitamin E Combined |
|
|
440 | (2) |
|
|
442 | (5) |
|
25.5.1 Rationale and Objectives |
|
|
442 | (1) |
|
25.5.2 Agent Formulations and Dose |
|
|
442 | (1) |
|
25.5.3 Trial Design and Outcome Ascertainment |
|
|
443 | (1) |
|
|
443 | (1) |
|
25.5.5 Primary Endpoint Results |
|
|
444 | (1) |
|
25.5.6 Secondary Endpoints, Adverse Outcomes, and Adherence |
|
|
444 | (3) |
|
25.6 Why Didn't SELECT Produce Expected Results? |
|
|
447 | (4) |
|
25.6.1 Acceptance of Null Hypothesis |
|
|
447 | (1) |
|
|
447 | (1) |
|
|
448 | (2) |
|
|
450 | (1) |
|
25.7 Implications and Future Directions |
|
|
451 | (7) |
|
|
452 | (1) |
|
|
452 | (1) |
|
Definitions of Words and Terms |
|
|
453 | (1) |
|
|
454 | (1) |
|
|
455 | (3) |
|
Chapter 26 Selenium in Autoimmune Thyroiditis |
|
|
458 | (21) |
|
|
|
|
|
|
458 | (3) |
|
26.2 Selenium Supplementation in Hashimoto Thyroiditis |
|
|
461 | (5) |
|
26.2.1 Effects of Selenium Supplementation on Thyroid Autoantibodies |
|
|
461 | (4) |
|
26.2.2 Effects of Selenium Supplementation on Thyroid Echogenicity |
|
|
465 | (1) |
|
26.2.3 Effects of Selenium Supplementation on Circulating Cytokine Production |
|
|
466 | (1) |
|
26.2.4 Effects of Selenium Supplementation on TSH and Thyroid Hormones |
|
|
466 | (1) |
|
26.3 Selenium Supplementation in Postpartum Thyroiditis |
|
|
466 | (1) |
|
26.4 Selenium Supplementation in Graves' Disease and Graves' Orbitopathy |
|
|
467 | (1) |
|
|
468 | (11) |
|
|
472 | (1) |
|
|
472 | (1) |
|
|
473 | (1) |
|
|
474 | (1) |
|
|
475 | (4) |
|
Chapter 27 Selenoproteins in Brain |
|
|
479 | (18) |
|
|
|
27.1 Selenoproteins in the Brain |
|
|
479 | (3) |
|
27.1.1 Mice Deficient in Selenoprotein P Paved the Way to the Discovery that Selenium is Essential for Brain Function |
|
|
479 | (1) |
|
27.1.2 Selenoprotein P and Its Endocytic Receptors Rationalize a Model of Selenium Transport to the Brain |
|
|
480 | (1) |
|
27.1.3 Most Selenoproteins are Expressed in Neurons |
|
|
481 | (1) |
|
27.2 Functions of Selenoproteins in the Brain |
|
|
482 | (4) |
|
27.2.1 Selenoproteins Are Essential for Neuronal Development and Survival |
|
|
483 | (1) |
|
27.2.2 Inhibitory Interneurons of the Parvalbumin+ Class are Most Sensitive to Impaired Selenoprotein Expression |
|
|
483 | (1) |
|
27.2.3 The Role of Glutathione Peroxidase 4 and Vitamin E |
|
|
484 | (1) |
|
27.2.4 Other Potentially Essential Selenoproteins |
|
|
485 | (1) |
|
27.3 Human Brain Disorders and Selenoproteins |
|
|
486 | (4) |
|
27.3.1 Mutations in Selenocysteine Synthase in Humans Lead to Progressive Cerebello Cerebral Atrophy |
|
|
487 | (1) |
|
27.3.2 Mutations in the SECISBP2 Gene in Humans Lead to a Multisystem Disorder also Involving the Central Nervous System |
|
|
487 | (1) |
|
27.3.3 Evidence that Selenoproteins are Related to Major Neurodegenerative Disorders |
|
|
488 | (2) |
|
|
490 | (7) |
|
|
490 | (1) |
|
Key Facts: Selenoprotein Biosynthesis |
|
|
490 | (1) |
|
Key Facts: Essential Selenoproteins and Biosynthetic Cofactors for the Brain |
|
|
491 | (1) |
|
Key Facts: Mutations in Genes Affecting Selenoprotein Expression |
|
|
491 | (1) |
|
|
492 | (1) |
|
|
492 | (1) |
|
|
493 | (4) |
|
Chapter 28 Selenoprotein H in Neuronal Cells |
|
|
497 | (19) |
|
|
|
|
28.1 Selenoprotein Biosynthesis |
|
|
497 | (1) |
|
28.2 The Functions of Selenoprotein H |
|
|
498 | (1) |
|
28.3 Mitochondrial Protective Effects of Selenoprotein H |
|
|
499 | (1) |
|
28.4 Effects of Selenoprotein H on Mitochondrial Biogenesis |
|
|
500 | (1) |
|
28.5 Selenoprotein H Regulates PGC-lα Upstream Signaling Pathways |
|
|
501 | (2) |
|
28.6 Effects of Selenium on the Mitochondrial Function and Biogenesis |
|
|
503 | (4) |
|
28.7 Selenium Affects Mitochondrial Dynamics |
|
|
507 | (9) |
|
|
508 | (1) |
|
|
508 | (1) |
|
Key Facts of PGC-la in Relationship to Mitochondrial Biogenesis |
|
|
508 | (1) |
|
Key Features of Mitochondrial Biogenesis |
|
|
509 | (1) |
|
|
509 | (1) |
|
Definitions of Word and Terms |
|
|
509 | (2) |
|
|
511 | (1) |
|
|
512 | (4) |
|
Chapter 29 Current Clinical Perspectives of Selenium in Vascular Function and Cardiomyopathy |
|
|
516 | (18) |
|
|
|
|
516 | (1) |
|
29.2 Selenium Deficiency and Relation to Cardiovascular Events |
|
|
517 | (1) |
|
29.3 Clinical Evidence of Selenium Impacting on Vascular Function |
|
|
518 | (4) |
|
29.3.1 Clinical Observational Studies |
|
|
518 | (1) |
|
29.3.2 Clinical Interventional Studies |
|
|
519 | (3) |
|
29.4 Selenium in Other Endothelial Dysfunction-Related Clinical Conditions |
|
|
522 | (1) |
|
29.4.1 Rheumatoid Arthritis |
|
|
523 | (1) |
|
|
523 | (1) |
|
29.5 Selenium Deficiency, Cardiomyopathy and Heart Failure |
|
|
523 | (1) |
|
29.6 Genetic Polymorphisms of Selenoprotein: Cardiovascular Implications |
|
|
524 | (1) |
|
29.7 The Selenium Paradox |
|
|
525 | (1) |
|
29.8 Current Recommendations and Future Directions |
|
|
525 | (9) |
|
|
526 | (1) |
|
|
526 | (1) |
|
The Key Facts of Heart Failure, Including Pathophysiological Features, Clinical Symptoms and Diagnosis |
|
|
527 | (1) |
|
Definitions of Words and Terms |
|
|
527 | (1) |
|
|
528 | (1) |
|
|
529 | (5) |
|
Chapter 30 Selenium and the Heart |
|
|
534 | (18) |
|
|
|
534 | (1) |
|
30.2 Selenium Deficiency and Cardiomyopathy |
|
|
535 | (1) |
|
|
535 | (1) |
|
30.3 Selenium and Ischemic Myocardial Diseases |
|
|
536 | (2) |
|
30.3.1 Myocardial Infarction |
|
|
536 | (1) |
|
30.3.2 Myocardial Ischemia-Reperfusion |
|
|
537 | (1) |
|
30.4 Doxorubicin (Adriamycin)-Induced Cardiomyopathy and Selenium |
|
|
538 | (1) |
|
30.5 Selenium, Redox-Methylation Balance and the Heart |
|
|
538 | (1) |
|
30.5.1 Selenium, via the Methionine-Homocysteine Cycle, Affects Redox and Methylation Potential |
|
|
539 | (1) |
|
30.5.2 Selenium and Myocardial Dysfunction: Role of Redox-Methylation Balance |
|
|
540 | (4) |
|
30.6 Selenistasis -- Selenium in Health and Disease |
|
|
544 | (1) |
|
|
545 | (7) |
|
|
546 | (1) |
|
|
546 | (1) |
|
Definitions of Words and Terms |
|
|
547 | (1) |
|
|
547 | (1) |
|
|
548 | (4) |
|
Chapter 31 Selenium and Kashin-Beck Disease |
|
|
552 | (20) |
|
|
|
|
31.1 The History of Kashin-Beck Disease |
|
|
552 | (4) |
|
31.1.1 Epidemiological Distribution |
|
|
553 | (1) |
|
31.1.2 Clinical and Radiographic Changes |
|
|
554 | (2) |
|
31.1.3 Hypothesis of Se Deficiency Causing KBD |
|
|
556 | (1) |
|
31.2 The Etiological Relationship between Se Deficiency and Kashin-Beck Disease |
|
|
556 | (3) |
|
31.2.1 Cross-Sectional Study |
|
|
556 | (2) |
|
31.2.2 Prospective Studies |
|
|
558 | (1) |
|
31.2.3 The Natural Decrease in KBD Prevalence |
|
|
558 | (1) |
|
31.3 Biological Changes Related to Low Se in KBD Patients |
|
|
559 | (2) |
|
31.3.1 Metabolic Disorders in Kashin-Beck Disease Caused by Se Deficiency |
|
|
559 | (1) |
|
31.3.2 Regulatory Factors and Gene Expression in KBD |
|
|
560 | (1) |
|
31.4 Short Tandem Repeats (STRs) and Single Nucleotide Polymorphisms (SNPs) in KBD Patients |
|
|
561 | (1) |
|
31.5 Animal KBD Model with Low-Se Diet |
|
|
562 | (1) |
|
31.6 The Preventive and Therapeutical Effect of Se Supplement |
|
|
563 | (4) |
|
31.6.1 The Effect of Se Supplements on Articular Chondrocytes |
|
|
564 | (1) |
|
31.6.2 Sodium Selenite Tablets |
|
|
564 | (1) |
|
|
565 | (1) |
|
31.6.4 Se-Fortified Wheat |
|
|
565 | (1) |
|
31.6.5 Se Supplement Combined with Other Elements |
|
|
566 | (1) |
|
31.6.6 Nano-Se-Chondroitin Sulfate |
|
|
567 | (1) |
|
|
567 | (5) |
|
|
567 | (1) |
|
Key Facts of Kashin-Beck Disease (KBD) |
|
|
567 | (1) |
|
Definitions of Words and Terms |
|
|
568 | (1) |
|
|
569 | (1) |
|
|
569 | (3) |
|
Chapter 32 Selenium, the Placenta and Trophoblast Mitochondrial Oxidative Stress |
|
|
572 | (17) |
|
|
32.1 The Importance of the Placenta to Lifelong Health |
|
|
572 | (1) |
|
32.2 Importance of Micronutrition to Placental Health |
|
|
573 | (1) |
|
32.3 Placental Oxidative Stress |
|
|
574 | (2) |
|
32.4 Mitochondrial Oxidative Stress |
|
|
576 | (3) |
|
32.5 The Role of Selenium in Human Health and Reproduction |
|
|
579 | (1) |
|
32.6 Importance of Selenium in Human Pregnancy |
|
|
580 | (9) |
|
|
583 | (1) |
|
|
583 | (1) |
|
Definitions of Words and Terms |
|
|
584 | (1) |
|
|
584 | (1) |
|
|
585 | (4) |
|
Chapter 33 Selenium and Antioxidant Microgels |
|
|
589 | (19) |
|
|
|
|
|
|
589 | (3) |
|
33.2 Antioxidant Microgels |
|
|
592 | (9) |
|
33.2.1 Microgels as "Smart" Materials to Build an Artificial Antioxidant |
|
|
592 | (4) |
|
33.2.2 Microgels as Platform to Construct a Synergistic Antioxidant Enzymatic System |
|
|
596 | (5) |
|
33.3 Summary and Perspective |
|
|
601 | (7) |
|
|
602 | (1) |
|
|
602 | (1) |
|
Key Facts of Antioxidants |
|
|
602 | (1) |
|
Key Facts of Enzyme Assay |
|
|
603 | (1) |
|
Definitions of Words and Terms |
|
|
603 | (1) |
|
|
604 | (1) |
|
|
605 | (3) |
Subject Index |
|
608 | |